Improving and Accelerating Therapeutic Development for Nervous System Disorders
Publisher: National Academies Press 2013
Number of pages: 116
The aim was to examine opportunities to accelerate early phases of drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials, explored how new and emerging tools and technologies may improve the efficiency of research, and considered mechanisms to facilitate a more effective and efficient development pipeline.
Home page url
Download or read it online for free here:
- U.S. Department of Health and Human Services
The publication, Approved Drug Products (commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act.
by Farid Badria (ed.) - InTech
The book focuses on three major areas: diagnosis, treatment, and prevention for a wide array of diseases; Cognitive and Psychological disorders, Inflammatory disorders, updated antihypertensive therapy and healing of ulcers with venous origin.
by Philip Rowe - BookBoon
All the basic concepts of pharmacokinetics are described, with an emphasis on understanding what parameters such as bioavailability and clearance tell us about the behaviour of a particular drug. The use of PKs in a drug developments covered.
- National Academies Press
Objectives: to examine the impact of and investment in genetic and genomic technologies and data in drug development; to examine the challenges for incorporating genomic technologies into drug development and to to remedy those challenges.